REVIVA PHARMACEUTICALS HOLDINGS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are RVPH insiders buying or selling?
REVIVA PHARMACEUTICALS HOLDINGS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since August 2018, Trabud has recorded 24 Form 4 filings for RVPH: 10 buys ($15.4M) and 14 sells ($6.7M).
Source: SEC EDGAR Form 4
Key Statistics (August 2018 – Nov 21, 2022)
Total Form 4 filings
24
SEC EDGAR
Insider filers
9
Insider buys (10)
$15.4M
Insider sells (14)
$6.7M
Insider sentiment
Net buyingNet insider flow of $8.8M in net buying since August 2018.
Recent RVPH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Purav Patel | Director | Purchase | 3.0K | $4.69 | $14.1K | SEC ↗ |
| Oct 3, 2022 | Prabhu Narayan | Chief Financial Officer | Purchase | 50.0K | $1.66 | $83.0K | SEC ↗ |
| Jun 30, 2022 | Prabhu Narayan | Chief Financial Officer | Purchase | 50.0K | $1.21 | $60.7K | SEC ↗ |
| Jun 3, 2021 | SAXENA PARAG | 10% Owner | Purchase | 1.3M | $3.75 | $5.0M | SEC ↗ |
| Dec 11, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 367.0K | $10.88 | $4.0M | SEC ↗ |
| Dec 9, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sale | 50.0K | $11.51 | $575.5K | SEC ↗ |
| Dec 4, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 261 | $11.00 | $2.9K | SEC ↗ |
| Dec 2, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 11.3K | $10.95 | $124.0K | SEC ↗ |
| Nov 25, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 30.7K | $10.90 | $334.8K | SEC ↗ |
| Nov 18, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1.3K | $10.90 | $14.5K | SEC ↗ |
| Nov 13, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 5 | $10.90 | $54.5 | SEC ↗ |
| Nov 10, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1 | $10.90 | $10.9 | SEC ↗ |
| Nov 4, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 57.6K | $10.85 | $625.1K | SEC ↗ |
| Nov 3, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sale | 40.0K | $10.99 | $439.8K | SEC ↗ |
| Oct 1, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 2 | $11.50 | $23 | SEC ↗ |
| Sep 21, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1.0K | $10.80 | $10.8K | SEC ↗ |
| Sep 16, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1 | $10.80 | $10.8 | SEC ↗ |
| May 15, 2020 | MIZUHO SECURITIES USA LLC | 10% Owner | Sale | 51.0K | $10.62 | $541.6K | SEC ↗ |
| Sep 4, 2018 | Tenzing LLC | 10% Owner | Purchase | 33.0K | $10.00 | $330.0K | SEC ↗ |
| Sep 4, 2018 | Rahul Nayar | Chief Executive Officer | Purchase | 33.0K | $10.00 | $330.0K | SEC ↗ |
| Sep 4, 2018 | SAXENA PARAG | Chairman of the Board | Purchase | 33.0K | $10.00 | $330.0K | SEC ↗ |
| Aug 24, 2018 | Rahul Nayar | Chief Executive Officer | Purchase | 310.0K | $10.00 | $3.1M | SEC ↗ |
| Aug 24, 2018 | SAXENA PARAG | Chairman of the Board | Purchase | 310.0K | $10.00 | $3.1M | SEC ↗ |
| Aug 24, 2018 | Tenzing LLC | 10% Owner | Purchase | 310.0K | $10.00 | $3.1M | SEC ↗ |
Showing the 24 most recent of 24 Form 4 filings for REVIVA PHARMACEUTICALS HOLDINGS, INC..
Most active RVPH insiders
- GLAZER CAPITAL, LLC11 filings
- Hudson Bay Capital Management LP2 filings
- Prabhu Narayan2 filings
- Rahul Nayar2 filings
- SAXENA PARAG2 filings
Ask anything about RVPH insider activity
Use Trabud's AI agent to query REVIVA PHARMACEUTICALS HOLDINGS, INC.'s Form 4 history in plain English — "Show me RVPH CEO purchases this year" or compare it against any other ticker.
Open the AI agentRVPH insider trading FAQ
Are REVIVA PHARMACEUTICALS HOLDINGS, INC. insiders buying or selling?
REVIVA PHARMACEUTICALS HOLDINGS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since August 2018, Trabud has recorded 24 Form 4 filings for RVPH: 10 buys ($15.4M) and 14 sells ($6.7M). Over the full record that is net buying of $8.8M.
How many insiders trade RVPH stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for REVIVA PHARMACEUTICALS HOLDINGS, INC.. The most recent filing was accepted on Nov 21, 2022.
Where does Trabud get RVPH insider trading data?
All RVPH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.